The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S
Related Articles
The Cold Hard Facts About Colon Cancer
Each year in the United States, nearly 150,000 people are diagnosed with colorectal cancer, and over 50,000 die from the disease. It is the second leading cause of cancer death, but there are effective ways to prevent the disease... Read More
Gluten Allergy: What To Do Next?
Celiac disease is one of the most common gastrointestinal diseases, affecting as many as 1 in 100 people. Gluten is a protein found in wheat, rye, and barley. When a person has celiac sprue, the immune system recognizes gluten as a... Read More